Inappropriate Sinus Tachycardia Registry

Launched by ATRICURE, INC. · Oct 28, 2021

Keywords

ClinConnect Summary

The Inappropriate Sinus Tachycardia Registry is a study that aims to collect information about the safety and effectiveness of special devices made by AtriCure. These devices are used to treat conditions known as Inappropriate Sinus Tachycardia (IST) and Postural Tachycardia Syndrome (POTS). The registry will gather data from various medical centers across the United States and other countries, looking at both past and current treatments to understand how well these devices work for patients.

To participate in this registry, individuals must be scheduled for or have already undergone a procedure using AtriCure devices for IST or POTS. Participants need to provide their written agreement to join the study. However, those involved in other studies that could affect the results, or those who do not meet specific safety requirements set by the FDA or local authorities, cannot enroll. If you decide to participate, you’ll be helping to gather important information that could improve treatment options for people with these conditions in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Subject is scheduled to undergo or has undergone a procedure to treat IST or POTS using one or more AtriCure devices.
• • 2. Subject is willing to provide written informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this Registry) or authorization per institution and geographical requirements
• Exclusion Criteria:
• • 1. Subject is enrolled in a concurrent study that may impact treatment outcome of IST or POTS.
• • 2. Subject with exclusion criteria required by FDA or local governance